SEC Form 4 · accession 0001209191-15-061528
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Duncan Higgons
Officer — Chief Operating Officer
Period of report
Jul 16, 2015
Accepted (ET)
Jul 17, 2015 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jul 16, 2015 | M | 8,264 | $0.3025 | A | 130,099 | D | |
| Common stock | Jul 16, 2015 | M | 11,736 | $0.3025 | A | 141,835 | D | |
| Common stockF3 | Jul 16, 2015 | S | 20,000 | $114.02 | D | 121,835 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F4 | $0.3025 | Jul 16, 2015 | M | 8,264 | D | — | Aug 12, 2019 | Common stock | 8,264 | 326,758 | D |
| Stock option (right to buy)F5 | $0.3025 | Jul 16, 2015 | M | 11,736 | D | — | Aug 12, 2019 | Common stock | 11,736 | 315,022 | D |
Explanation of responses
- F1This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F3The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $113.02 to $115.20. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on May 18, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- F5This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on June 13, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter.